A carregar...
Complete response after rechallenge with trabectedin in a patient with previously responding high-grade undifferentiated sarcoma
Evidence supporting rechallenge in patients responding to first exposure to trabectedin is limited. We report on a 39-year-old woman with advanced high-grade undifferentiated sarcoma (US) retreated twice with trabectedin after first response. The patient presented in June 2006 with an abdominal mass...
Na minha lista:
| Publicado no: | Anticancer Drugs |
|---|---|
| Main Authors: | , , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Lippincott Williams & Wilkins
2016
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5010279/ https://ncbi.nlm.nih.gov/pubmed/27348763 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/CAD.0000000000000398 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|